Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Production Efficiency01:01

Production Efficiency

Net production efficiency (NPE) is the efficiency at which organisms assimilate energy into biomass for the next trophic level. Due to low metabolic rates and less energy spent on thermoregulatory processes, the NPE of ectotherms (cold-blooded animals) is 10 times higher than endotherms (warm-blooded animals).
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
The Scientific Method01:32

The Scientific Method

The scientific method is a detailed, empirical problem-solving process used by biologists and other scientists. This iterative approach involves formulating a question based on observation, developing a testable potential explanation for the observation (called a hypothesis), making and testing predictions based on the hypothesis, and using the findings to create new hypotheses and predictions.Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updating the PRISMA reporting guideline for scoping reviews: a scoping review.

Journal of clinical epidemiology·2026
Same author

Responsible Integration of Artificial Intelligence in Rapid Reviews: A Position Statement From the Cochrane Rapid Reviews Methods Group.

Cochrane evidence synthesis and methods·2025
Same author

Overview of evidence synthesis types and modes.

Journal of clinical epidemiology·2025
Same author

Rapid reviews methods series: guidance on rapid scoping, mapping and evidence and gap map ('Big Picture Reviews').

BMJ evidence-based medicine·2025
Same author

Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocol.

JBI evidence synthesis·2025
Same author

Key concepts in rapid reviews: an overview.

Journal of clinical epidemiology·2024

Related Experiment Videos

Systematic reviews can be produced and published faster.

Margaret Sampson1, Kaveh G Shojania, Chantelle Garritty

  • 1Chalmers Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada. msampson@cheo.on.ca

Journal of Clinical Epidemiology
|May 13, 2008
PubMed
Summary

Systematic reviews take a median of 61 weeks to publish. Faster production of health care evidence syntheses is achievable through streamlined author and publisher processes, improving review currency.

Related Experiment Videos

Area of Science:

  • Health Services Research
  • Evidence Synthesis
  • Medical Informatics

Background:

  • Systematic reviews are crucial for evidence-based healthcare.
  • The currency of systematic reviews impacts their applicability and reliability.
  • Understanding publication timelines is essential for improving the efficiency of evidence dissemination.

Purpose of the Study:

  • To determine typical and achievable publication times for systematic reviews.
  • To compare publication speeds across different document types (journals, HTA reports, Cochrane reviews).
  • To identify factors influencing the time from final search to publication.

Main Methods:

  • A cohort of 156 systematic reviews of treatment interventions published between 1995 and 2005 was analyzed.
  • Data on search dates, manuscript submission, acceptance, publication, and MEDLINE indexing were extracted.
  • Publication times were calculated from the final search date to the publication date.

Main Results:

  • The median time from final search to publication was 61 weeks (IQR: 33-87 weeks).
  • Optimal performance benchmarks included: final search to submission (10 weeks), submission to acceptance (11 weeks), and acceptance to publication (12 weeks).
  • Publication times varied between journals, Health Technology Assessment reports, and Cochrane Collaboration reviews (though specific differences were not detailed in the abstract).

Conclusions:

  • Reducing production time can significantly improve the currency of systematic reviews.
  • Both authors and publishers play a role in accelerating the production of health care evidence syntheses.
  • Timely publication of systematic reviews is vital for timely healthcare decision-making.